Xuesai Zhang Selected Research

Immunoconjugates (Immunoconjugate)

11/2020

Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody-Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuesai Zhang Research Topics

Disease

8	Neoplasms (Cancer) 01/2023 - 05/2016
2	Triple Negative Breast Neoplasms 01/2023 - 08/2017
2	Lung Neoplasms (Lung Cancer) 11/2020 - 01/2019
2	Thrombosis (Thrombus) 01/2020 - 08/2017
2	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2016
2	Neoplasm Metastasis (Metastasis) 01/2019 - 08/2017
1	Disease Progression 11/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Adenocarcinoma 08/2017
1	Brain Neoplasms (Brain Tumor) 05/2017
1	Glioma (Gliomas) 05/2017

Drug/Important Bio-Agent (IBA)

3	Thromboplastin (Tissue Factor)IBA 01/2023 - 08/2017
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
2	LigandsIBA 01/2021 - 05/2017
2	Tyrosine Kinase InhibitorsIBA 11/2020 - 01/2019
2	Sirolimus (Rapamycin)FDA Link 01/2019 - 05/2016
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2019 - 05/2016
2	Mechanistic Target of Rapamycin Complex 2IBA 01/2019 - 05/2016
1	Chemokine CXCL9IBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	AntigensIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 11/2020
1	Adenosine (Adenocard)FDA LinkGeneric 11/2020
1	EnzymesIBA 11/2020
1	pertuzumabIBA 01/2020
1	Trastuzumab (Herceptin)FDA Link 01/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	AntibodiesIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	CollagenIBA 01/2020
1	FibrinIBA 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2019
1	PAR-2 ReceptorIBA 08/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2017
1	cyclic arginine-glycine-aspartic acid peptideIBA 05/2017
1	MicellesIBA 05/2017
1	HydrocarbonsIBA 05/2017
1	arginyl-glycyl-aspartic acidIBA 05/2017
1	Peptides (Polypeptides)IBA 05/2017
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 05/2016
1	ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)IBA 05/2016

Therapy/Procedure

5	Therapeutics 01/2023 - 05/2017
2	Immunotherapy 01/2023 - 11/2020
1	Drug Therapy (Chemotherapy) 01/2023
1	Intravenous Administration 08/2017